Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Secures $37M Private Equity Funding

Premium

HAMBURG, Germany --Sequenom, a transnational pharmacogenomics technology company headquartered here, completed a $37 million financing round through equity funding last week. Participants in the round included Nomura International, Deutsche Bank, Haspa Bank, Euroventures, Vertex Capital, Alafi Capital, and Value Management and Research. Previous investors, including Techno Venture Management, Alpinvest International, Global Life Sciences, Dresdner Kleinwort Benson, and SR One, also participated.

Hubert Koster, Sequenom's president and CEO, said the funding will enable the company to complete full commercial launch of its proprietary DNA analysis products and to expand its manufacturing, sales, and service support structure.

By year's end, the company said it will launch its DNA MassArray Basic System, a modular, semiautomated platform that includes an array mass spectrometer, nanoplotter, and bioinformatics workstation, and its DNA MassArray APL system, which offers robotics and software to meet high-throughput demands in industrial settings.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.